Date:
December 14, 2023
Time:
12pm-1pm
Place:
N-225
David Raleigh (faculty)
"Two wrongs apparently make one wrong a little less wrong."
Ling, A.L., Solomon, I.H., Landivar, A.M. et al. Clinical trial links oncolytic immunoactivation to survival in glioblastoma. Nature 623, 157–166 (2023). https://doi.org/10.1038/s41586-023-06623-2
Max Pass (student)
“The one that didn’t get away: a distinct intratumoral population of cDC1s that amplify CD8 T cell responses"
Meiser, P. et al. A distinct stimulatory cDC1 subpopulation amplifies CD8+ T cell responses in tumors for protective anti-cancer immunity. Cancer Cell 0, (2023).
Coaches: Matt Spitzer, PhD & Max Krummel, PhD